< Back to situations

[ORGANIZATION]

Foundayo

Featured in 5 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

310 clusters · 1152 sources · last updated

Latest: L'Oreal reports GLP-1 weight loss drugs are reshaping beauty and skincare markets

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric health and respiratory health. Cardiovascular benefits remain strong, th

[ACTIVE] [BUSINESS] [DE] [ES] [EU]

EMA recommendation for Eli Lilly obesity medication

2 clusters · 15 sources · last updated

Latest: Eli Lilly's Foundayo receives positive EMA recommendation for obesity and diabetes

The European Medicines Agency (EMA) has issued a positive recommendation via its Committee for Medicinal Products for Human Use (CHMP) for Eli Lilly’s oral medication, Foundayo (orforglipron). The drug is a small-molecul